These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 5830976)

  • 1. Blood clotting and fibrinolytic studies in patients with muscular dystrophy.
    Bond TP; Guest MM
    Tex Rep Biol Med; 1964 Dec; 22():Suppl 1:886-9. PubMed ID: 5830976
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of venous occlusion and local exercise on fibrinolytic activity and clotting time of blood.
    Malathi A; Parulkar VG
    Indian J Physiol Pharmacol; 1985; 29(3):175-7. PubMed ID: 3836195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fibrinolysis and fibrinolytic agents. Physico-chemical data].
    Fontaine L; Chabert J
    Angeiologie; 1970; 22(6):335-8 passim. PubMed ID: 5493454
    [No Abstract]   [Full Text] [Related]  

  • 4. [Post-mortem fibrinolysis in man].
    Harms D
    Veroff Morphol Pathol; 1971; 87():1-74. PubMed ID: 5144656
    [No Abstract]   [Full Text] [Related]  

  • 5. Motor nerve conduction in Duchenne type of muscular dystrophy.
    Jayam AV; Raju TN; Pandya SS; Desai AD
    Neurol India; 1970 Mar; 18(1):8-12. PubMed ID: 5439386
    [No Abstract]   [Full Text] [Related]  

  • 6. [Fibrinolytic hemorrhages in childhood and their therapy with PAMBA].
    Hoffmann W; Mey U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 87(1):88-93. PubMed ID: 4173887
    [No Abstract]   [Full Text] [Related]  

  • 7. [Anomalies of regulation of the muscular microcirculation in children having progressive muscular dystrophy compared to normal children of the same age].
    Demos J; Treumann F; Schroeder W
    Rev Fr Etud Clin Biol; 1968 May; 13(5):467-83. PubMed ID: 5674734
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study of muscular function in progressive muscular dystrophy patients using the ergometrer].
    Abe I; Sakurai M; Watanabe T; Igarashi T; Kunii M
    Iryo; 1968 Dec; 22(12):1398-402. PubMed ID: 5717707
    [No Abstract]   [Full Text] [Related]  

  • 9. Functional and biochemical responses of children with progressive muscular dystrophy on standard physical exertion.
    Nesvadba Z; Hosková L; Zdánský P; Groh J
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1981; 24(2):215-52. PubMed ID: 6975972
    [No Abstract]   [Full Text] [Related]  

  • 10. "Fibrinolytic capacity" in healthy volunteers as estimated from effect of venous occlusion of arms.
    Robertson BR; Pandolfi M; Nilsson IM
    Acta Chir Scand; 1972; 138(5):429-36. PubMed ID: 5055974
    [No Abstract]   [Full Text] [Related]  

  • 11. EMG parameters changes in the effort pattern at various load in dystrophic muscle.
    Hausmanowa-Petrusewicz I; Kopec J
    Electromyogr Clin Neurophysiol; 1984; 24(1-2):121-36. PubMed ID: 6697945
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacological aspects of fibrinolysis].
    Prino G; Mantovani M
    Boll Chim Farm; 1969 Dec; 108(12):727-60 passimf. PubMed ID: 4911753
    [No Abstract]   [Full Text] [Related]  

  • 13. [Correlation of blood coagulation, fibrinolysis and lipids with age, physical activity, hormonal status and nutrition].
    Cańizares C; De Leon C; Cańizares F; Martinez A
    Sangre (Barc); 1971; 16(4):377-86. PubMed ID: 5128058
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hematology in childhood].
    Exadaktylos P
    Z Arztl Fortbild (Jena); 1970 Sep; 64(17):891-6. PubMed ID: 5481873
    [No Abstract]   [Full Text] [Related]  

  • 15. [Determination of fibrinolytic and antifibrinolytic activity of blood in epidemic Botkin's disease].
    Arakelov RA; Abagian IA
    Zh Eksp Klin Med; 1969; 9(4):61-3. PubMed ID: 5376572
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative studies of the effect of fibrinolytic inhibitors (synthetic and naturally occurring substances) on coagulation and fibrinolytic systems in vitro and in vivo, and their clinical applications.
    Matsuoka M; Sakuragawa N; Yoneyama Y
    Acta Med Biol (Niigata); 1969 Mar; 16(3):105-20. PubMed ID: 4239124
    [No Abstract]   [Full Text] [Related]  

  • 17. [Role of the initial level of plasminogen activator in changes in fibrinolysis].
    Andreenko GV; Liutova LV; Karabasova MA; Podorol'skaia LV; Serebriakova TN
    Fiziol Zh SSSR Im I M Sechenova; 1983 Mar; 69(3):380-5. PubMed ID: 6343132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Characteristics of blood coagulation in patients with aneurysmal bone cysts].
    Krisiuk AP; Kutsenko TA; Sivak NF; Shamraĭ AE
    Ortop Travmatol Protez; 1983 Sep; (7):51-3. PubMed ID: 6634111
    [No Abstract]   [Full Text] [Related]  

  • 19. Slow motor nerve conduction in myotonic dystrophy.
    Roohi F; List T; Lovelace RE
    Electromyogr Clin Neurophysiol; 1981; 21(2-3):97-105. PubMed ID: 7262015
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical studies on the changes in clotting factor before and after extracorporeal circulation].
    Orumuka Y
    Kumamoto Igakkai Zasshi; 1970 Jun; 44(6):497-511. PubMed ID: 5468447
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.